Sector: health
Conviction from: NASDAQ
52-week range: 88.00250.06
Develops, manufactures and markets DNA sequencing and array-based systems, consumables and software used in genomic research and clinical diagnostics.
4 tracked filer(s) hold this · 0 opened, 1 added, 3 trimmed in 30-JUN-2026
Aggregate 13FScore 61 — mean of 4 scored holder(s) · buyers (new/add) avg 76. Higher = the smart money in this name has the better track record.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|
| Steve Cohen / Point72 | 76 | Added +25% | 95,500 | $16,791,765 | 0.0% |
| Keith Meister / Corvex | 72 | Trimmed -26% | 2,830,552 | $497,695,958 | 15.2% |
| Ancora | 40 | Trimmed -59% | 48 | $8,440 | 0.0% |
| Bridgewater | 56 | Trimmed -1% | 12,586 | $2,212,996 | 0.0% |
Beyond 13F — activists, insiders, politicians & research
1 disclosed trade(s) by 1 filer(s).
2 disclosed trade(s) by 1 filer(s).